Literature DB >> 27641935

Postpercutaneous Nephrolithotomy Systemic Inflammatory Response Syndrome Is Not Associated With Unplanned Readmission.

Rachel A Moses1, Deepak Agarwal2, Eric P Raffin3, Boyd R Viers2, Vidit Sharma2, Amy E Krambeck2, Vernon M Pais3.   

Abstract

OBJECTIVE: To investigate the incidence of systemic inflammatory response syndrome (SIRS) following percutaneous nephrolithotomy (PCNL) and evaluate any association with unplanned 90-day readmission.
METHODS: We retrospectively reviewed consecutive patients undergoing PCNL in 2 dedicated endourologic practices between 2009 and 2013. We collected patient demographics, perioperative culture data, and operative characteristics. SIRS was defined as having 2 or more of the following: maximum white blood cell count >12,000 or <4000, temperature >38 or <34°C, heart rate >90, and respiratory rate >20 within the first 24 hours following PCNL. Proportions between groups were compared to identify significant associations.
RESULTS: We identified 389 patients undergoing PCNL and 43% (167 of 389) met SIRS criteria, more commonly in patients with multiple PCNL accesses (OR 2.3; CI: 1.1-4.8, P = .025). Readmission was required in 8% (31 of 389), most commonly for infection (n = 21). Although possession of a struvite stone was associated with unplanned readmission (16% vs 4%, P < .01), SIRS in the absence of fever within 48 hours postoperative was not associated with readmission (29.4% vs 25.8%, P = .837).
CONCLUSION: Nearly half of the patients undergoing PCNL met the criteria for SIRS within the first postoperative day. There was no association between SIRS and unplanned readmission in the postoperative PCNL patient. Despite discharge during the first postoperative day, patients with SIRS (without fever or struvite stones) had no increased risk for unplanned return. Our findings suggest that the development of SIRS immediately following PCNL does not preclude safe discharge on the first postoperative day.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27641935     DOI: 10.1016/j.urology.2016.09.012

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Performance of SOFA, qSOFA and SIRS to predict septic shock after percutaneous nephrolithotomy.

Authors:  Yonghan Peng; Wei Zhang; Yalong Xu; Ling Li; Weixing Yu; Jianwen Zeng; Shaoxiong Ming; Ziyu Fang; Zeyu Wang; Xiaofeng Gao
Journal:  World J Urol       Date:  2020-04-10       Impact factor: 4.226

2.  Intraoperative dexmedetomidine attenuates postoperative systemic inflammatory response syndrome in patients who underwent percutaneous nephrolithotomy: a retrospective cohort study.

Authors:  Fang Tan; Xiaoliang Gan; Yingqing Deng; Xiaoyun Li; Na Guo; Ziqing Hei; Qianqian Zhu; Zhuang-Gui Chen; Shaoli Zhou
Journal:  Ther Clin Risk Manag       Date:  2018-02-14       Impact factor: 2.423

3.  Perioperative application of dexmedetomidine for postoperative systemic inflammatory response syndrome in patients undergoing percutaneous nephrolithotomy lithotripsy: results of a randomised controlled trial.

Authors:  Yingqing Deng; Fang Tan; Qianqian Zhu; Shaoli Zhou; Xiaoliang Gan; Xiaoyun Li; Mian Ge; Chulian Gong; Ziqing Hei
Journal:  BMJ Open       Date:  2018-11-03       Impact factor: 2.692

4.  The retrospective study of perioperative application of dexamethasone and furosemide for postoperative anti-inflammation in patients undergoing percutaneous nephrolithotomy.

Authors:  Taiguo Qi; Xia Qi; Xiude Chen; Xunbo Jin
Journal:  Int Urol Nephrol       Date:  2021-01-07       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.